Genmab — September 2025
-
a bit more on Guggenheim's thoughts - Genmab upgraded at Guggenheim; says Darzalex related growth concerns are overblown https://www.msn.com/en-us/money/markets/genmab-upgraded-at-guggenheim-says-darzalex-related-growth-concerns-are-overblown/ar-AA1N8I83
-
Forventelig start på dagen når toldmure igen er aktuelle.
-
Medicinalsektoren bør spidse ører næste uge: Trump-administrationen rygtes på vej med nyt https://proinvestor.com/investornyt/1365483/medicinalsektoren-bor-spidse-orer-naeste-uge-trump-administrationen-rygtes-pa-vej-med-nyt
-
if the 15% EU trade agreement holds i don't see any further impact for now. Genmab will have to work with US manufacturers for future drugs, but that was already clear, see no change there. But you never know for sure with Trump, so sector nervousness remains...
-
Genmab IS affected because the stock is very volatile and as such when the sector is rocked... Genmab is always in for a ride both ways
-
-
Godmorgen
-
Godmorgen
-
USA Told: EU har stadig en 15 % aftale - såvidt vidt vi ved https://proinvestor.com/boards/128610
-
Genmab rygtes i fremskredne forhandlinger om køb af hollandsk biotekselskab https://proinvestor.com/investornyt/1366091/genmab-rygtes-i-fremskredne-forhandlinger-om-kob-af-hollandsk-biotekselskab
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind